Eli Lilly has released a new vial version of its blockbuster weight loss drug Zepbound for around half the price of its original injectable pen, as its battle with Novo Nordisk to boost production for the wildly popular medicine heats up.
礼来公司发布了其畅销减肥药Zepbound的新的小瓶版本，价格约为其原始注射笔的一半，该公司与诺和诺德公司为提高这种广受欢迎的药物的产量展开了激烈竞争。
您已阅读8%（315字），剩余92%（3676字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。